143 related articles for article (PubMed ID: 16234512)
41. Equivalent survival in patients with advanced stage IB-II and III-IVA cervical cancer treated by adjuvant surgery following chemoradiotherapy.
Carcopino X; Houvenaeghel G; Buttarelli M; Esterni B; Tallet A; Goncalves A; Jacquemier J
Eur J Surg Oncol; 2008 May; 34(5):569-75. PubMed ID: 17531428
[TBL] [Abstract][Full Text] [Related]
42. The outcome of laparoscopic radical hysterectomy and lymphadenectomy for cervical cancer: a prospective analysis of 295 patients.
Chen Y; Xu H; Li Y; Wang D; Li J; Yuan J; Liang Z
Ann Surg Oncol; 2008 Oct; 15(10):2847-55. PubMed ID: 18649105
[TBL] [Abstract][Full Text] [Related]
43. Surveillance testing among survivors of early-stage breast cancer.
Keating NL; Landrum MB; Guadagnoli E; Winer EP; Ayanian JZ
J Clin Oncol; 2007 Mar; 25(9):1074-81. PubMed ID: 17369571
[TBL] [Abstract][Full Text] [Related]
44. Prognosis of early cervical cancer (FIGO Stages IA2, IB, and IIA) in northern Norway predicted by malignancy grading score and objective morphometric image analysis.
Eggen T; Arnes M; Moe B; Straume B; Orbo A
Int J Gynecol Pathol; 2007 Oct; 26(4):447-56. PubMed ID: 17885497
[TBL] [Abstract][Full Text] [Related]
45. Gynecologic Cancer Intergroup (GCIG) proposals for changes of the current FIGO staging system.
Petru E; Lück HJ; Stuart G; Gaffney D; Millan D; Vergote I;
Eur J Obstet Gynecol Reprod Biol; 2009 Apr; 143(2):69-74. PubMed ID: 19195765
[TBL] [Abstract][Full Text] [Related]
46. Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer.
Lee JM; Lee KB; Lee SK; Park CY
J Obstet Gynaecol Res; 2007 Jun; 33(3):288-93. PubMed ID: 17578357
[TBL] [Abstract][Full Text] [Related]
47. Comparison of examination of the entire uterine cervix with routine cervical sampling in hysterectomy specimens from women with endometrial cancer.
Nayar AG; Cross PA; Bulmer JN; Deen S; El-Sherif A
J Clin Pathol; 2008 May; 61(5):621-2. PubMed ID: 18006669
[TBL] [Abstract][Full Text] [Related]
48. Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer.
Horn LC; Fischer U; Raptis G; Bilek K; Hentschel B
Gynecol Oncol; 2007 Nov; 107(2):310-5. PubMed ID: 17826822
[TBL] [Abstract][Full Text] [Related]
49. [Evaluation of the practical efficacy of the FIGO Classification for Early Invasive Squamous Cervical Cancer].
Ivanov S; Batashki I
Akush Ginekol (Sofiia); 2006; 45 Suppl 1():11-3. PubMed ID: 16673656
[TBL] [Abstract][Full Text] [Related]
50. Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix.
Macdonald OK; Chen J; Dodson M; Lee CM; Gaffney DK
Am J Clin Oncol; 2009 Aug; 32(4):411-6. PubMed ID: 19451800
[TBL] [Abstract][Full Text] [Related]
51. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
[TBL] [Abstract][Full Text] [Related]
52. Can preoperative MRI accurately evaluate nodal and parametrial invasion in early stage cervical cancer?
Chung HH; Kang SB; Cho JY; Kim JW; Park NH; Song YS; Kim SH; Lee HP
Jpn J Clin Oncol; 2007 May; 37(5):370-5. PubMed ID: 17556538
[TBL] [Abstract][Full Text] [Related]
53. Radiochemotherapy combined with regional pelvic hyperthermia induces high response and resectability rates in patients with nonresectable cervical cancer > or =FIGO IIB "bulky".
Sreenivasa G; Hildebrandt B; Kümmel S; Jungnickel K; Cho CH; Tilly W; Böhmer D; Budach V; Felix R; Wust P
Int J Radiat Oncol Biol Phys; 2006 Nov; 66(4):1159-67. PubMed ID: 16979843
[TBL] [Abstract][Full Text] [Related]
54. Collecting direct non-health care and time cost data: application to screening and diagnosis of cervical cancer.
Cantor SB; Levy LB; Cárdenas-Turanzas M; Basen-Engquist K; Le T; Beck JR; Follen M
Med Decis Making; 2006; 26(3):265-72. PubMed ID: 16751325
[TBL] [Abstract][Full Text] [Related]
55. [Unanswered questions in the management of cervical cancer].
Ebert AD; Ulrich U; Beckmann MW; Schneider A
Zentralbl Gynakol; 2006 Feb; 128(1):23-6. PubMed ID: 16450283
[TBL] [Abstract][Full Text] [Related]
56. Concurrent chemoradiotherapy with nedaplatin after radical hysterectomy in patients with stage IB and II cervical cancer.
Kobayashi Y; Ohara T; Wada Y; Okuda Y; Kondo H; Okuma Y; Suzuki N; Gomi H; Kiguchi K; Ishizuka B
J Obstet Gynaecol Res; 2009 Jun; 35(3):490-4. PubMed ID: 19527388
[TBL] [Abstract][Full Text] [Related]
57. Incorporating laparoscopy in the practice of a gynecologic oncology service: actual impact beyond clinical trials data.
Ghezzi F; Cromi A; Uccella S; Siesto G; Zefiro F; Bolis P
Ann Surg Oncol; 2009 Aug; 16(8):2305-14. PubMed ID: 19459012
[TBL] [Abstract][Full Text] [Related]
58. Routine pretreatment evaluation of patients with gynecologic cancer.
Lindell LK; Anderson B
Obstet Gynecol; 1987 Feb; 69(2):242-6. PubMed ID: 3808510
[TBL] [Abstract][Full Text] [Related]
59. Role of imaging in cancer of the cervix. American College of Radiology. ACR Appropriateness Criteria.
Hricak H; Mendelson E; Böhm-Vélez M; Bree R; Finberg H; Fishman EK; Laing F; Sartoris D; Thurmond A; Goldstein S
Radiology; 2000 Jun; 215 Suppl():925-30. PubMed ID: 11037518
[No Abstract] [Full Text] [Related]
60. [Controversies on the staging of microinvasive cervix carcinoma].
Di Leo S; Caragliano L; Cassaro N; Meli MT; Consalvo P; Caschetto S
Minerva Ginecol; 2000 Sep; 52(9):345-9. PubMed ID: 11189964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
